Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00055731
Status:
COMPLETED
Last Update Posted:
2023-01-18
First Post:
2003-03-06
Brief Title:
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
Sponsor:
UNICANCER
Organization:
UNICANCER
Organization Data
Organization:
UNICANCER
Class:
OTHER
Study ID:
GETUG-12 - UC-01600203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
UNICANCER
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| AstraZeneca | INDUSTRY |
| Sanofi | INDUSTRY |